Navigation Links
Research highlights role of protein pair in obesity regulation
Date:2/12/2010

CINCINNATINew research by University of Cincinnati (UC) scientists implicates a new protein in obesity development and highlights a protein pair's "team effort" in regulating obesity and insulin resistance.

Jorge Moscat, PhD, chair of UC's cancer and cell biology department, says that proteins p62 and ERK are involved in adipogeneis, (the development of adipocytes, or fat cells). His new study shows precisely how this duo works together.

The study is published online in advance of print Friday, Feb. 12, 2010, in the journal EMBO Reports, and will appear in print in the March 1, 2010, edition.

Earlier research led by Moscat showed that removing or "knocking out" p62 in mice led to the development of obesity and insulin resistance in adulthood. These mice used less energy and created more fat cells than the control group, even with the same diet and activity levels.

Targeting p62 mutations or deficiencies seemed to be a logical next step for potential obesity treatments; however, Moscat says, p62 is not an easy target due to its lack of enzymatic action. In other words, it does not catalyze reactions in a way that would be key for the success of targeted drug therapy. In addition, missing or mutated p62 has also been linked to cancer development.

Moscat and his team instead decided to focus their attention on the action of another less-understood protein, ERK, which interacts with p62.

"Thoughts about ERK's role in obesity have been controversial," says Moscat. "One theory suggested that it was to restrain production of fat cells. Our study shows a much more devious role for ERK."

In the new study, Moscat and his team bred mice without p62 and ERK. These "double knockouts" did not develop obesity like the p62 knockouts did, indicating that ERK was the obesity-inducing culprit.

The team's findings show that p62 works to suppress the action of ERK, so without p62, ERK activity goes uncontrolled.

Moscat says that ERK serves as a better target for obesity therapies because it could be inhibited without affecting p62.


'/>"/>

Contact: Dama Kimmon
dama.kimmon@uc.edu
513-558-4519
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
2. GUMCs Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine
3. MSU researcher linking breast cancer patients with alternative therapies
4. Researchers create drug to keep tumor growth switched off
5. Tiny fruit fly could offer big clues in fight against obesity, researcher says
6. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
7. New Research Examines Impact of Health Care Reform on Regional Health Plans
8. Prevention Is Key Research Goal for Premature Babies, Scientists Say
9. Stuttering Foundation Hails New Research
10. Gladstones Robert Mahley to receive Research!America advocacy award
11. International Diabetes Federation awards $2 million to 9 global diabetes research projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... handheld devices. Through an educational webinar, they will present the line of epMotion ... to learn how easy you can automate everyday pipetting tasks. , Ideal for ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
(Date:8/18/2017)... ... 2017 , ... The Golseth Agency, a Texas based insurance management and financial ... regional charity campaign organized to provide support to Christina Upchurch and her two children ... and her children returned from out of town to find her husband passed away ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... HIGH POINT, N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., ... epilepsy is rumored to be in the beginning stages of an IPO. ... billion annually on epilepsy medications with the average cost of a prescription ... ... Another staggering figure is ...
(Date:8/11/2017)... Israel , Aug. 11, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... on Monday, August 14 and host a conference call ... quarter 2017 operating and financial results and its strategy ... will be hosted by Erez Raphael , Chief ...
(Date:8/7/2017)... , Aug. 7, 2017 Insightin ... member acquisition, retention, and engagement, announced the selection ... Strategy and Product Development, effective as of February 2017. ... and technology implementation strategy for our clients. Wood ... experience in consulting and business analytics within the ...
Breaking Medicine Technology: